Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Peptonic Medical

0.00 SEK

-20.00 %

Less than 1K followers

PMED

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-20.00 %
-55.56 %
-55.56 %
-59.60 %
-36.51 %
-68.25 %
-98.25 %
-99.86 %
-99.95 %

Peptonic Medical is a biomedical company that conducts research and development of pharmaceuticals and medical devices in the field of women's health. The company's vision is to offer treatments for women-specific diseases and medical conditions. For example, hormone-free products are being developed for the treatment of vaginal atrophy and vaginal dryness. Peptonic Medical has its headquarters in Bromma.

Read more
Market cap
16.58M SEK
Turnover
303.99K SEK
Revenue
14.79M
EBIT %
-131.51 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/5
2026

Interim report Q1'26

10/6
2026

General meeting '26

19/8
2026

Interim report Q2'26

All
Press releases
ShowingAll content types
Regulatory press release2/27/2026, 7:00 AM

PEPTONIC Medical AB: Peptonic Medical AB (publ) - Publishes Year-end report for 2025

Peptonic Medical
Regulatory press release2/27/2026, 7:00 AM

PEPTONIC Medical AB: Peptonic Medical AB (publ) - Publicerar Bokslutskommuniké för 2025

Peptonic Medical
Regulatory press release2/26/2026, 7:00 AM

PEPTONIC Medical AB: Peptonic Medical AB - Board of Directors appoints Daniel Rudeklint as interim CEO

Peptonic Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/26/2026, 7:00 AM

PEPTONIC Medical AB: Peptonic Medical AB - styrelsen utser Daniel Rudeklint till interim VD

Peptonic Medical
Regulatory press release2/25/2026, 11:47 AM

PEPTONIC Medical AB: Peptonic Medical AB announces termination of liquidity provider agreement

Peptonic Medical
Regulatory press release2/25/2026, 11:41 AM

PEPTONIC Medical AB: Peptonic Medical AB meddelar uppsägning av likviditetsgaranti

Peptonic Medical
Regulatory press release2/18/2026, 1:00 PM

PEPTONIC Medical AB: Peptonic meddelar sista dag för handel i BTU och första dag för handel med teckningsoptioner av serie TO6

Peptonic Medical
Regulatory press release2/18/2026, 1:00 PM

PEPTONIC Medical AB: Peptonic announces the last day of trading in BTU and first day of trading in TO6 warrants

Peptonic Medical
Regulatory press release2/12/2026, 5:30 PM

PEPTONIC Medical AB: Peptonics styrelse beslutar om en riktad nyemission av units till emissionsgaranter i samband med den avslutade företrädesemissionen

Peptonic Medical
Regulatory press release2/12/2026, 5:30 PM

PEPTONIC Medical AB: Peptonic's Board of Directors resolves on a directed issue of units to guarantors in connection with the completed rights issue

Peptonic Medical
Regulatory press release1/29/2026, 9:15 PM

PEPTONIC Medical AB: Peptonic Medical AB offentliggör utfall i företrädesemissionen

Peptonic Medical
Regulatory press release1/29/2026, 9:15 PM

PEPTONIC Medical AB: Peptonic Medical AB announces outcome of the rights issue

Peptonic Medical
Regulatory press release1/29/2026, 10:45 AM

PEPTONIC Medical AB: Peptonic Medical AB ändrar datum för offentliggörande av bokslutskommuniké

Peptonic Medical
Regulatory press release1/29/2026, 10:45 AM

PEPTONIC Medical AB: Peptonic Medical AB changes date for publication of year-end report

Peptonic Medical
Regulatory press release1/23/2026, 7:30 AM

PEPTONIC Medical AB: Sista dag för handel med uniträtter i Peptonics företrädesemission

Peptonic Medical
Regulatory press release1/23/2026, 7:30 AM

PEPTONIC Medical AB: Last day of trading with unit rights in Peptonic's rights issue

Peptonic Medical
Regulatory press release1/22/2026, 10:03 AM

PEPTONIC Medical AB: Peptonic Medical publicerar en verksamhetsuppdatering med anledning av avslutad rekonstruktion och pågående företrädesemission

Peptonic Medical
Regulatory press release1/22/2026, 7:30 AM

PEPTONIC Medical AB: Peptonic Medical publishes business update following completed restructuring and ongoing rights issue

Peptonic Medical
Regulatory press release1/14/2026, 7:30 AM

PEPTONIC Medical AB: The subscription period in Peptonic's rights issue of units starts today

Peptonic Medical
Regulatory press release1/14/2026, 7:30 AM

PEPTONIC Medical AB: Teckningsperioden i Peptonics företrädesemission av units inleds idag

Peptonic Medical
Forum discussions
Annual report released: FULL YEAR 2022 (Jan-Dec) Net sales of products 43,634 (31,643) tkr Gross profit 23,394 (19,070) tkr, 54% (60%) Operating loss -33,606 (-73,718) tkr Loss per share -0.15 (-0.38) kr The good thing is that sales have continued to grow. They also boasted about...
3/20/2023, 12:12 PM
by Old_man
8
I quickly found out that a new rights issue is on the way. For every current share, you would receive 4 new shares. And the price, if you then buy/exercise them, would be 0.01 SEK/share.
4/17/2024, 8:11 AM
by artuzo
3
Peptonic Medical (PMED:SS) today announced that it has signed a non-exclusive agreement with the medical technology company Siemens Healthineers for the distribution of Peptonic’s portfolio of diagnostic products for vaginal health. The agreement with Siemens Healthineers is global...
4/20/2023, 2:07 PM
by Old_man
3
STOCKHOLM (Nyhetsbyrån Direkt) Medtech company Peptonic Medical has decided to file an application for corporate restructuring. “The decision is an extraordinary measure due to a long-term strained liquidity situation and aims to create conditions for a stable and profitable business...
3/13/2025, 10:55 AM
by Old_man
2
Peptonic Medical AB (publ) (“Peptonic”) announced today that the company has agreed with the world’s largest retail chain Walmart to begin selling Peptonic’s self-test for bacterial vaginosis. The US is an important market. It is very gratifying that Walmart has decided to sell our...
10/11/2023, 8:04 AM
by Old_man
2
2023-06-15 13:00:00 - Cision International PEPTONIC Medical AB : Peptonic and Pharmiva sign letter of intent to merge and create a leading intimate women’s health company The FemTech companies PEPTONIC medical AB (“Peptonic”), listed on Spotlight Stock Market, and Pharmiva AB (publ...
6/15/2023, 12:42 PM
by Old_man
2
Peptonic Medical AB (publ) today announced that an arbitration court in China has ruled in favor of Peptonic in a dispute with Yuanjia Biotechnology Co., Ltd. In November 2020 and February 2021, Peptonic Medical shipped goods to Yuanjia Bio in China for a total value of 406,000 EUR...
6/9/2023, 7:30 AM
by Old_man
2
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.